Iris Dorbian

Cryptocurrency platform Liquid.com picks up funding

IDG Capital led the Series C round for Liquid.com, a global cryptocurrency platform. The funding puts the company at a valuation of over $1 billion.

Deepwatch scores $23 mln Series A

Deepwatch, a provider of intelligence-driven managed security services, has raised $23 million in Series A funding. ABS Capital Partners led the round. As a result of the transaction, Michael Avon, a venture partner with ABS Capital, will join Deepwatch's board of directors.

Fintech startup Pagaya lands $25 mln Series C

New York and Tel Aviv-based Pagaya, a fintech startup, has secured $25 million in Series C funding. Oak HC/FT led the round.

Squelch nabs $12 mln

Redwood City, California-based Squelch Inc, a provider of customer experience optimization solutions, has secured $12 million in funding. The investors were Shasta Ventures, Correlation Ventures and Tenaya Capital.

Hungry books $8 mln Series A

Arlington, Virginia-based Hungry, an online marketplace that connects independent chefs with the business and events catering market, has raised $8 million in Series A financing. Sands Capital Ventures and Motley Fool Ventures led the round.

CIC garners funding for UK startups

Cambridge Innovation Capital has raised 150 million pounds. The cornerstone investor was the University of Cambridge. The capital will be used to back CIC's current portfolio as well as invest in startups originating from the University of Cambridge. Goldman Sachs was the placement agent.

HammerTech amasses $10 mln in Arrowroot-led round

Australia and Seattle-based HammerTech, a mobile provider of health, safety and quality software for the construction industry, has raised $10 million in funding. Arrowroot Capital led the round. As part of the transaction, Chuck Haling and Matt Klein from Arrowroot Capital will be joining the board.

Biotech firm Candel Therapeutics reels in $22.5 mln Series C

Candel Therapeutics, a biotech firm, has raised $22.5 million in Series C financing. Northpond Ventures led the round. In addition to the funding, Dr. Michael P. Rubin, founder and CEO of Northpond Ventures, will join Candel Therapeutics' board of directors.

Valar Ventures targets $150 mln for fifth fund

Valar Ventures is seeking to raise $150 million for its fifth fund, according to an SEC filing. Based in New York, the venture firm was founded by Peter Thiel.

Elvie racks up $42 mln Series B

London-based Elvie, a health and lifestyle brand developing smarter technology for women, has secured $42 million in Series B funding. IPGL led the round with participation from Octopus Ventures and Impact Ventures UK.